Qiagen Cuts Q3 Earnings Forecast Following Terrorist Attacks | GenomeWeb

NEW YORK, Sept. 21 – Qiagen, of Venlo, the Netherlands, has slashed its third-quarter earnings estimates after disruptions in air traffic following last week's terrorist attacks on the United States resulted in a sharp drop in sales.

Qiagen, which manufactures products for nucleic acid purification, said it now expected to post third-quarter earnings of four cents a share, compared with a previous estimate of seven cents a share. The company expects to report net sales of $63 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.